2004;24(12):695-717. Finally, subcutaneous insulin aspart every 1 or 2 hours was a well tolerated and cost-effective alternative to a standard intravenous protocol of regular insulin in patients ...

Regular insulin, which is often used in pregnancy ... in pregnant women with Type 1 or Type 2 diabetes ( Table 4). Insulin aspart was the second rapidly acting analogue introduced, approved ...

Biocon Biologics and Civica, Inc. on Thursday announced a strategic collaboration agreement to expand access and affordability of Insulin Aspart in the United States. According to the company’s ...

(MENAFN- PR Newswire) Under the terms of the agreement, Biocon Biologics will supply Insulin Aspart drug substance to Civica, Inc., who will use the drug substance to produce Insulin Aspart drug ...